Investigating Pericarditis Diagnosis in a Tertiary Pericardial Center: A Descriptive Study
- PMID: 41260143
- PMCID: PMC12666822
- DOI: 10.1016/j.jacadv.2025.102335
Investigating Pericarditis Diagnosis in a Tertiary Pericardial Center: A Descriptive Study
Abstract
Background: Pericarditis diagnosis can be challenging due to its nonspecific presentation, which may lead to frequent misdiagnosis.
Objectives: In this study, the authors aimed to report the rate of misdiagnosed pericarditis and describe the characteristics of these patients.
Methods: Between September 2022 and September 2023, patients referred to the Pericardial Center with a diagnosis of pericarditis were enrolled in a prospective registry. Data were collected using a standardized history and physical examination template. Diagnosis was established according to the 2015 European Society of Cardiology guidelines. The prevalence of misdiagnosed pericarditis was calculated. Demographics, comorbidities, symptoms, laboratory results, and imaging were compared between the accurately diagnosed (group 1) and misdiagnosed pericarditis cohorts (group 2).
Results: A total of 170 patients were included; the mean age was 49.1 years. Thirty-five percent of patients were misdiagnosed. Demographics were similar in both groups. Significant differences were found between group 1 and group 2) in coronary artery disease (17.3% vs 5.0%, P = 0.02), valvular disease (23.6% vs 8.3%, P = 0.01), and atrial fibrillation (24.5% vs 6.7%, P < 0.01). Significant late gadolinium enhancement on magnetic resonance imaging, raised inflammatory markers, electrocardiogram changes, and specific pericardial pain were more common in the accurately diagnosed group (P < 0.05). COVID-19 infection was significantly higher in the misdiagnosed group (16.7% vs 6.4%, P < 0.05), whereas cardiac surgery was significantly lower (3.3% vs 18.2%, P < 0.05).
Conclusions: Thirty-five percent of patients referred to the pericardial center are misdiagnosed with pericarditis. Inflammatory markers and late gadolinium enhancement on magnetic resonance imaging can help refine the diagnosis. COVID-19 infection is associated with higher rates of misdiagnosis.
Keywords: LGE-MRI; long-COVID; misdiagnosis; pericarditis.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding support and author disclosures Dr Klein receives research grants from Kiniksa, Cardiol Therapeutics, and Ventyx Scientific; and serves on the advisory Boards of Kiniksa, Cardiol Therapeutics, and Ventyx Scientific. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
-
- Adler Y., Charron P., Imazio M., et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the european society of cardiology (ESC)Endorsed by: the european association for cardio-thoracic surgery (EACTS) Eur Heart J. 2015;36(42):2921–2964. - PMC - PubMed
-
- Chiabrando J.G., Bonaventura A., Vecchié A., et al. Management of acute and recurrent pericarditis: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(1):76–92. - PubMed
-
- Gouriet F., Levy P.-Y., Casalta J.-P., et al. Etiology of pericarditis in a prospective cohort of 1162 cases. Am J Med. 2015;128(7):784.e1–784.e8. - PubMed
-
- Imazio M., Hoit B.D. Post-cardiac injury syndromes. An emerging cause of pericardial diseases. Int J Cardiol. 2013;168(2):648–652. - PubMed
LinkOut - more resources
Full Text Sources
